Differential activation of eosinophils by bacteria associated with asthma

International Archives of Allergy and Immunology

Volumn 161, Issue , 2013, Pages 16-22

  Hosoki, Koa ^a   Nakamura, Akiko ^b   Kainuma, Keigo ^a   Sugimoto, Mayumi ^a   Nagao, Mizuho ^a   Hiraguchi, Yukiko ^a   Tanida, Hisashi ^a   Tokuda, Reiko ^a   Wada, Hideo ^b   Nobori, Tsutomu ^b   Suga, Shigeru ^a   Fujisawa, Takao ^a  

^a MIE NATIONAL HOSPITAL   (Japan)

^b MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bronchial asthma; Eosinophils; Haemophilus influenzae; Prevotella sp.; Staphylococcus aureus

Indexed keywords

EOSINOPHIL PROTEIN X; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ASTHMA; CELL ACTIVATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; DENSITY GRADIENT CENTRIFUGATION; EFFECTOR CELL; EOSINOPHIL; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN CELL; IMMUNOMAGNETIC SEPARATION; NORMAL HUMAN; PATHOGENESIS; PREVOTELLA; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; STAPHYLOCOCCUS AUREUS; ARTICLE; BACTERIUM; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; SECRETION (PROCESS);

ASTHMA; BACTERIA; CELLS, CULTURED; CYTOKINES; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; HAEMOPHILUS INFLUENZAE; HUMANS; PREVOTELLA; STAPHYLOCOCCUS AUREUS; SUPEROXIDES;

MLCS; MLOWN;

EID: 84880552362     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000350338     Document Type: Conference Paper

References (38)

1. Busse WW, Lemanske RF Jr: Asthma. N Engl J Med 2001; 344:350-362.
2. Turvey SE, Broide DH: Innate immunity. J Allergy Clin Immunol 2010; 125:S24-S32.
3. Busse WW, Lemanske RF Jr, Gern JE: Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010; 376:826-834.
4. Bisgaard H, Hermansen MN, Buchvald F, Lo-land L, Halkjaer LB, Bonnelykke K, Brasholt M, Heltberg A, Vissing NH, Thorsen SV, Stage M, Pipper CB: Childhood asthma after bacterial colonization of the airway in neo-nates. N Engl J Med 2007; 357:1487-1495.
5. Hollams EM, Hales BJ, Bachert C, Huvenne W, Parsons F, de Klerk NH, Serralha M, Holt BJ, Ahlstedt S, Thomas WR, Sly PD, Holt PG: Th2-associated immunity to bacteria in teenagers and susceptibility to asthma. Eur Respir J 2010; 36:509-516.
6. Huang YJ, Nelson CE, Brodie EL, Desantis TZ, Baek MS, Liu J, Woyke T, Allgaier M, Bristow J, Wiener-Kronish JP, Sutherland ER, King TS, Icitovic N, Martin RJ, Calhoun WJ, Castro M, Denlinger LC, Dimango E, Kraft M, Peters SP, Wasserman SI, Wechsler ME, Boushey HA, Lynch SV: Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011; 127:372-381 e1-e3.
7. Lehtinen P, Jartti T, Virkki R, Vuorinen T, Leinonen M, Peltola V, Ruohola A, Ruus-kanen O: Bacterial coinfections in children with viral wheezing. Eur J Clin Microbiol Infect Dis 2006; 25:463-469.
8. Hilty M, Burke C, Pedro H, Cardenas P, Bush A, Bossley C, Davies J, Ervine A, Poulter L, Pachter L, Moffatt MF, Cookson WO: Disordered microbial communities in asthmatic airways. PLoS ONE 2010; 5:e8578.
9. Expert panel report 3 (epr-3): Guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol 2007; 120:S94-S138.
10. Shamri R, Xenakis JJ, Spencer LA: Eosino-phils in innate immunity: an evolving story. Cell Tissue Res 2011; 343:57-83.
11. Hosoki K, Nakamura A, Nagao M, Hiraguchi Y, Tokuda R, Wada H, Nobori T, Fujisawa T: Differential activation of eosinophils by 'pro-biotic' Bifidobacterium bifidum and 'pathogenic' Clostridium difficile. Int Arch Allergy Immunol 2010; 152(suppl 1):83-89.
12. Hosoki K, Nakamura A, Nagao M, Hiraguchi Y, Tanida H, Tokuda R, Wada H, Nobori T, Suga S, Fujisawa T: Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor. J Leukoc Biol 2012; 92: 333-341.
13. Fujisawa T, Kato Y, Nagase H, Atsuta J, Terada A, Iguchi K, Kamiya H, Morita Y, Kitaura M, Kawasaki H, Yoshie O, Hirai K: Chemokines induce eosinophil degranula-tion through CCR-3. J Allergy Clin Immunol 2000; 106:507-513.
14. Nagata M, Sedgwick JB, Kita H, Busse WW: Granulocyte macrophage colony-stimulating factor augments ICAM-1 and VCAM-1 activation of eosinophil function. Am J Respir Cell Mol Biol 1998; 19:158-166.
15. Frigas E, Loegering DA, Solley GO, Farrow GM, Gleich GJ: Elevated levels of the eosino-phil granule major basic protein in the sputum of patients with bronchial asthma. Mayo Clin Proc 1981; 56:345-353.
16. Broide DH, Gleich GJ, Cuomo AJ, Coburn DA, Federman EC, Schwartz LB, Wasserman SI: Evidence of ongoing mast cell and eosino-phil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991; 88:637-648.
17. Motojima S, Frigas E, Loegering DA, Gleich GJ: Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis 1989; 139:801-805.
18. Plager DA, Henke SA, Matsuwaki Y, Madaan A, Squillace DL, Dierkhising RA, Kita H: Pimecrolimus reduces eosinophil activation associated with calcium mobilization. Int Arch Allergy Immunol 2009; 149:119-126.
19. Agosti JM, Altman LC, Ayars GH, Loegering DA, Gleich GJ, Klebanoff SJ: The injurious effect of eosinophil peroxidase, hydrogen peroxide, and halides on pneumocytes in vitro. J Allergy Clin Immunol 1987; 79:496-504.
20. Wu W, Chen Y, Hazen SL: Eosinophil per-oxidase nitrates protein tyrosyl residues. Implications for oxidative damage by nitrating intermediates in eosinophilic inflammatory disorders. J Biol Chem 1999; 274:25933-25944.
21. Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ: Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med 1999; 160: 216-220.
22. Boguniewicz M, Leung DY: Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242: 233-246.
23. Kowalski ML, Cieslak M, Perez-Novo CA, Makowska JS, Bachert C: Clinical and immu-nological determinants of severe/refractory asthma (SRA): association with staphylococ-cal superantigen-specific IgE antibodies. Allergy 2011; 66:32-38.
24. Bachert C, van Steen K, Zhang N, Holtappels G, Cattaert T, Maus B, Buhl R, Taube C, Korn S, Kowalski M, Bousquet J, Howarth P: Specific IgE against Staphylococcus aureus en-terotoxins: an independent risk factor for asthma. J Allergy Clin Immunol 2012; 130: 376-381.e8.
25. Kuroda-Morimoto M, Tanaka H, Hayashi N, Nakahira M, Imai Y, Imamura M, Yasuda K, Yumikura-Futatsugi S, Matsui K, Nakashima T, Sugimura K, Tsutsui H, Sano H, Nakanishi K: Contribution of IL-18 to eosinophilic airway inflammation induced by immunization and challenge with Staphylococcus aureus proteins. Int Immunol 2010; 22:561-570.
26. Huvenne W, Callebaut I, Plantinga M, Vanoirbeek JA, Krysko O, Bullens DM, Ge-vaert P, Van Cauwenberge P, Lambrecht BN, Ceuppens JL, Bachert C, Hellings PW: Staph-ylococcus aureus enterotoxin B facilitates allergic sensitization in experimental asthma. Clin Exp Allergy 2010; 40:1079-1090.
27. Barnes PJ: The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 2008; 118:3546-3556.
28. Ying S, Robinson DS, Varney V, Meng Q, Tsi-copoulos A, Moqbel R, Durham SR, Kay AB, Hamid Q: TNF-α mRNa expression in allergic inflammation. Clin Exp Allergy 1991; 21: 745-750.
29. Bradding P, Roberts JA, Britten KM, Monte-fort S, Djukanovic R, Mueller R, Heusser CH, Howarth PH, Holgate ST: Interleukin-4,-5, and-6 and tumor necrosis factor-α in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am J Respir Cell Mol Biol 1994; 10:471-480.
30. Thomas PS, Yates DH, Barnes PJ: Tumor necrosis factor-α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am J Respir Crit Care Med 1995; 152:76-80.
31. Franchimont D, Martens H, Hagelstein MT, Louis E, Dewe W, Chrousos GP, Belaiche J, Geenen V: Tumor necrosis factor alpha decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexametha-sone: potential regulation of the glucocorti-coid receptor. J Clin Endocrinol Metab 1999; 84:2834-2839.
32. Amrani Y, Panettieri RA Jr, Frossard N, Bron-ner C: Activation of the TNF-alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells. Am J Respir Cell Mol Biol 1996; 15:55-63.
33. Sullivan DE, Ferris M, Pociask D, Brody AR: Tumor necrosis factor-alpha induces transforming growth factor-β1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol 2005; 32:342-349.
34. Saraiva M, O'Garra A: The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010; 10:170-181.
35. Tournoy KG, Kips JC, Pauwels RA: Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness. Clin Exp Allergy 2000; 30:775-783.
36. Bisgaard H, Hermansen MN, Bonnelykke K, Stokholm J, Baty F, Skytt NL, Aniscenko J, Kebadze T, Johnston SL: Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ 2010; 341:c4978.
37. Essilfie AT, Simpson JL, Dunkley ML, Morgan LC, Oliver BG, Gibson PG, Foster PS, Hansbro PM: Combined Haemophilus influ-enzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma. Thorax 2012; 67: 588-599.
38. Ahren IL, Eriksson E, Egesten A, Riesbeck K: Nontypeable Haemophilus influenzae activates human eosinophils through beta-glucan receptors. Am J Respir Cell Mol Biol 2003; 29: 598-605.